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A 110-kDa protein was copurified with adeno-associated virus type 2 (AAV-2) virions after CsCl density gradient isopycnic
centrifugation. Amino acid sequence of peptides derived from this protein after tryptic digestion, monoclonal antibody
production, and Western blot analysis showed that the copurified protein was the major nucleolar phosphoprotein, human
nucleolin. Virus overlay assays demonstrated that AAV-2 capsid specifically bound to the human nucleolin, and immunopre-
cipitation studies confirmed the in vitro binding of nucleolin and intact AAV-2 capsids but not denatured viral proteins.
Double-immunofluorescence staining of infected cells showed that AAV capsid and nucleolin were colocalized in both
cytoplasm and nucleus. In addition, when cytoplasmic and nuclear fractions were extracted from AAV-infected KB cells at
different time points postinfection, immunoprecipitation data and Western blotting showed that AAV capsid formation and
nucleolin interact specifically and share their subcellular localization in infected cells. With the known functions of nucleolin
in the synthesis of rRNA and ribosome assembly, binding to single-stranded DNA, and acting as a shuttle between cytoplasm
and nucleolus, our data showing that AAV-2 capsid binds specifically to nucleolin both in vitro and in vivo suggest a key role
of nucleolin in AAV-2 replication, particularly in capsid assembly.
Key Words: nucleolin; adeno-associated virus 2 (AAV-2); binding.I
n
s
f
t
b
A
m
w
p
g
c
q
d
a
a
e
w
c
a
V
h
b
t
a
aINTRODUCTION
Adeno-associated virus type 2 (AAV-2), a human par-
ovirus, is a defective parvovirus that requires coinfec-
ion with a helper virus such as adenovirus. The viral
enome is a linear single-stranded DNA, 4679 nucleo-
ides in length with inverted terminated repeats (Berns
nd Bohenzky, 1987; Srivastava et al., 1983). Two large
pen reading frames (ORFs) have been identified within
he genome: the left ORF encodes the nonstructural Rep
rotein, which is involved in the regulation of replication
nd transcription and is necessary for production of the
ingle-stranded progeny genome; the right ORF encodes
he capsid proteins, and the capsid, with a diameter of
0–30 nm, consists of three structural proteins, VP1, VP2,
nd VP3, with molecular masses of 90, 72, and 60 kDa,
espectively (Rose et al., 1971; Buller and Rose, 1978).
As part of our studies to obtain large amounts of
urified AAV-2 capsids for AAV-2 binding studies, we
outinely obtained a 110-kDa protein that copurified with
he virus even after repeated CsCl isopycnic centrifuga-
ion and especially when infected cells were disrupted
y sonication. We therefore decided to identify this pro-
ein further and to elucidate its role in AAV-2 replication.
1 To whom correspondence and reprint requests should be ad-
ressed at Building 10, Room 7C218, National Institutes of Health, 9000
ockville Pike, Bethesda, MD 20892. Fax: (301) 496-8396. E-mail:
iuJ@gwgate.nhlbi.nih.gov.373RESULTS
dentification of the AAV copurified protein as
ucleolin
When AAV-2 was purified from infected 293 cells by
olubilization in 2% deoxycholate, three cycles of CsCl
ractionation with collection of the 1.39 g/ml density frac-
ion, and analysis of the purified virus on SDS–8% PAGE
y silver staining, an extra protein band just above the
AV VP1 capsid protein with an estimated molecular
ass of 110 kDa was uniformly detected (Fig. 1A); there
as no evidence of adenoviral or AAV Rep proteins in the
reparations. The 110-kDa protein was excised from the
el and sent for microsequencing (Harvard Microbio-
hemistry Facility, Cambridge, MA). Amino acid se-
uence was obtained from two peptides after tryptic
igestion, with both peptides matching the known amino
cid sequence of human nucleolin (peptide 1, VFGNEIK,
a 338–344; peptide 2, VTLDWAK, aa 635–641; Srivastava
t al., 1989). Confirmation of the identity of the protein
as obtained by Western blotting using both rabbit poly-
lonal antibody to human nucleolin (Kibbey et al., 1995)
nd mouse monoclonal antibodies (Chen et al., 1991;
aldez et al., 1995; Deng et al., 1996). All antibodies to
uman nucleolin showed a strong band with specific
inding to the 110-kDa protein (Fig. 1B), with an addi-
ional band at 90 kDa. To exclude the possibility that the
ntibodies were cross-reacting with AAV-2 VP1, the VP1
nd VP1/2 unique sequences of AAV-2 were expressed0042-6822/99
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374 QIU AND BROWNs His fusion and tested by Western blot with the nucleo-
in antibodies. None of the nucleolin antibodies bound to
ither the VP1 or the VP2 fusion proteins (Fig. 1C), indi-
ating that the 90-kDa protein was the previously re-
orted degraded form of nucleolin, relatively abundant in
ondividing cells (Chen et al., 1991) and with similar
inding activity to full-length nucleolin (Lee et al., 1998).
roduction and specificity of monoclonal antibodies
Further support for the identification of the copurifying
rotein as nucleolin was obtained by testing the anti-
enic specificity of monoclonal antibodies obtained after
mmunization of mice with the AAV purified from 293
FIG. 1. SDS–PAGE and Western blotting identification of copurified
10-kDa protein. (A) Purified AAV-2 virions from infected 293 cells were
un on SDS–8% PAGE and visualized by silver staining; the copurified
rotein is indicated by the arrow above VP1 of AAV-2. (B) Proteins
eparated on SDS–PAGE were blotted onto nitrocellulose membranes
nd detected with rabbit anti-human nucleolin polyclonal antibodies
nd different monoclonal antibodies to human nucleolin, CC98, D3,
S3, and MS4. The arrows indicate protein bands reacting with
ucleolin antibodies. (C) The unique VP1 and VP2 sequences were
xpressed as His fusion proteins, separated by SDS–PAGE, blotted
nto nitrocellulose, and Western blotted with antibodies to His, AAV
P1, and nucleolin antibodies as above and antibody Ep1a. Lane 1, VP
/2; lane 2, VP 1; arrows indicate the size of the expected fusion
roteins.ells. Antibodies with specificity to intact virions only
IE1a), denatured VP2/VP1 (IWP2), and denatured VP3/
P2/VP1 (IWP3) were obtained, as well as antibody that
etected the 110-kDa protein band (EP1a; Fig. 2A). Anti-
ody EP1a did not detect AAV capsid protein, but bound
o both a crude nucleolin extract and purified human
ucleolin (Fig. 2B).
AV-2 specifically binds to nucleolin in vitro
The method of purification of AAV-2 was critical for
dentifying the copurifying nucleolin: when AAV was pre-
ared from tissue culture supernatant we did not find
ucleolin; sonication of infected cells increased the
mount of nucleolin. Therefore, a purified AAV prepara-
ion, prepared from infected KB cell tissue culture super-
atant and non-infected cells and shown by Western
lotting to be Ad5-, Rep protein-, and nucleolin-free, was
dentified and used for iodination and binding assays.
he indirect viral overlay assay was performed with AAV
opurified nucleolin and purified nucleolin. Although dif-
erent cellular preparations had differing amounts of in-
act or degraded nucleolin, AAV capsids bound to both
he 110-kDa full-length and the 90-kDa degraded bands
f nucleolin (Fig. 3). Specificity of the binding was dem-
nstrated by competition of cold (unlabeled) AAV with hot
iodinated) AAV in the direct viral overlay assay (Fig. 4). In
he presence of excess (50 times) cold AAV labeled AAV
inding was significantly reduced and completely
locked in the presence of 100-fold cold virus. Similar
tudies using an excess of Ad5 (50 times) or albumin
250 times) showed no reduction in binding (data not
hown).
FIG. 2. Monoclonal production by immunizing Balb/c mouse with
urified AAV with the 110-kDa protein. 100 mg purified AAV was emul-
ified with TiterMax adjuvant and used to immunize Balb/c mice.
ybridomas were produced by fusion spleen cells with Sp2/0 cells and
creened by Western blotting. (A) AAV copurified with 110-kDa protein
as separated on SDS–PAGE, and the transferred proteins were de-
ected by hybridoma supernatant of EP1a, IWP2, IWP3, and IE1a. Bands
ere developed by DAB substrate. (B) Purified nucleolin extract (lane 1)
nd crude nucleolin (lane 2) were analyzed by Western blotting using
P1a hybridoma supernatant at a 1:1000 dilution. Bands were detected
y chemiluminscent substrate.
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375NUCLEOLIN BINDS TO AAV-2 CAPSIDTo exclude the possibility that nucleolin binding was
ediated through virus-associated DNA (Prasad and
rempe, 1995), purified AAV-2 preparations were pre-
reated with DNase I or mung bean nuclease (500 U/ml
t 37°C for 45 min in appropriate digestion buffers).
here was no significant difference in binding of AAV
reparations with or without digestion (data not shown).
n contrast treatment of AAV with 0.025% trypsin com-
letely removed the AAV-associated nucleolin. Neither
eoxycholate (2%) nor a low concentration SDS (0.1%)
FIG. 3. Indirect virus overlay assay of AAV copurified 110-kDa protein.
opurified 110-kDa proteins from AAV infected 293 cells (lane 1) and KB
ells (lane 2) and purified human nucleolin (lane 3) were run on
DS–PAGE and electrotransferred to nitrocellulose membrane, and the
ransferred strips were incubated with or without (control) purified
AV-2 virions. Capsid binding was detected by monoclonal A20 and
RPO-conjugated anti-mouse antibody and development with chemi-
uminescent substrate. In some preparations (as in lane 2) the nucleo-
in was degraded to its 90-kDa form.
FIG. 4. Competitive direct virus overlay assay. AAV copurified human
ucleolin was separated on SDS–8% PAGE and transferred to nitrocel-
ulose membrane. The membrane was blocked, cut into strips, and
ncubated with 10 mg of 125I-labeled AAV (lane 1), plus 500 mg of
nlabeled AAV (lane 2), and plus 1000 mg of unlabeled AAV (lane 3).
nlabeled virus control (lane 4). Bands were developed by exposure
ith X-ray film.issociated the nucleolin, and a higher concentration of
DS (0.5%) destroyed the AAV capsids. There was in-
omplete dissociation of AAV-nucleolin with high salt
oncentration (4 M, pH 5.0). Binding studies were also
erformed with AAV viral proteins separated by SDS–
AGE, incubation with crude nucleolin extract, and de-
ection of binding with nucleolin-specific antibody. In
hese studies there was no evidence of binding of
ucleolin to denatured capsid proteins even at a high
oncentration (25 mg/5 ml incubation buffer, Fig. 5). In
omplementary experiments all of the dissociated AAV
P proteins also failed to bind to blotted denatured
ucleolin under the same conditions in which intact AAV
apsids bound in virus overlay assays (data not shown).
Although nucleolin is primarily a nuclear and cytoplas-
ic protein, it has also been identified in the cell mem-
rane (Avalosse et al., 1989; Deng et al., 1996; de Ver-
ugo et al., 1995), and we determined whether AAV could
ind to nucleolin in cell membrane fractions. Viral overlay
ssays were performed with AAV permissive cells (293,
B, and HeLa S3 cells) and the AAV-2 nonpermissive cell
ine Mo-7e (Ponnazhagan et al., 1996). In both permissive
nd nonpermissive cells, an AAV-binding protein band at
10 kDa was observed (data not shown). To identify this
10-kDa binding protein band, solubilized membrane
ractions were incubated with AAV-coated magnetic
eads and the resultant AAV-binding proteins were iden-
ified in a pull-down assay (Fig. 6). Protein staining of the
recipitated product showed a strong protein band at
50 kDa and a weaker 110-kDa band, with virtual clear-
ng of other membrane proteins. Western blotting with
onoclonal antibody to nucleolin confirmed the 110-kDa
and to be nucleolin and indicated that AAV binds to
FIG. 5. Nucleolin overlay binding assay. Purified AAV-2 was run on
DS–7% PAGE, transferred to membrane, and incubated with crude
ucleolin at 1 mg/ml (lane 1) or 5 mg/ml (lane 2) and B1 monoclonal
ntibody as a control (lane 3). Binding was detected by anti-nucleolin
onoclonal antibody, CC98. Bands were developed by further incuba-
ion with HRPO-conjugated goat anti-mouse secondary antibody and
hemiluminescent substrate.
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376 QIU AND BROWNucleolin in cell membrane fractions (Fig. 6A); the stron-
er 150-kDa band was identified by AAV viral overlay
Fig. 6B) to be the protein previously described by our
aboratory as an AAV-binding protein and possible AAV
ellular receptor (Mizukami et al., 1996). However, al-
hough flow cytometry data showed that nucleolin was
resent on the cell surface of the AAV-2 permissive cells
eLa S3 and K562, and also the nonpermissive cells
o-7e, we could not detect nucleolin on the cell surface
f the AAV-permissive cells HEp-2 and RD (Fig. 7).
AV capsid colocalized with nucleolin in the nuclei
nd cytoplasm of infected cells
By immunofluorescence AAV capsids could not be
etected in the nucleus until at least 12 h postinfection,
onsistent with the previous report that AAV capsid is
ormed in the nucleolus at approximately 14 h postinfec-
ion (Wistuba et al., 1997). After this time period, immu-
ofluorescence with antibody to both AAV capsid and
ucleolin showed that both proteins were localized in the
ucleus 18 h postinfection, in both nucleus and cyto-
lasm 24 h postinfection, and in the pericytoplasm 36 h
ostinfection (Fig. 8). At all time points the nucleolin and
AV capsid protein show similar staining patterns, sug-
esting that they are intimately associated within the cell
s soon as capsid formation occurs and suggesting a
ossible role for nucleolin in capsid assembly.
To confirm this association, cytoplasm and nuclear
ractions were extracted from AAV-infected KB cells at 0,
2, 18, and 24 h postinfection and immunoprecipitation
FIG. 6. Indirect virus overlay assay and Western blotting analysis of
AV ligand precipitated proteins from solubilized HeLa S3 membrane
raction. Solubilized membrane fraction (50 mg) of HeLa S3 cells was
ulled down by AAV coated magnetic beads and the precipitated
roteins were run on SDS–6% PAGE and blotted. (A) Western blotting:
ransferred strips were detected by CC98 antibodies. Lane 1, AAV
recipitated protein; lane 2, total solubilized membrane fraction (50 mg).
B) Indirect virus overlay assay of total solubilized membrane fraction
as in lane 2), incubated with purified AAV-2 virions, and then incubated
ith A20 monoclonal antibodies.xperiments were performed with monoclonal antibod-
es to intact AAV capsid (A20) and human nucleolin
CC98). Precipitated proteins were analyzed by Western
lotting with a monoclonal antibody that reacts with all
hree denatured capsid proteins (VP1, VP2, and VP3) of
AV-2 (B1). Both monoclonal antibody CC98 and A20
recipitated AAV capsid as soon as the capsid was
ormed (18 h postinfection, Fig. 9), and more capsid was
recipitated from the nucleus than from the cytoplasm by
oth A20 and CC98. Monoclonal antibody CC98 could
ot pull down AAV capsid in the absence of nucleolin,
nd the specificity of coimmunoprecipitation was further
onfirmed by the use of monoclonal antibody to avb5 as
control.
DISCUSSION
In this study we showed that human nucleolin binds to
AV capsids even after standard AAV purification proce-
ures and that this association between AAV capsids
nd nucleolin occurs both in vitro and in vivo. Immuno-
recipitation and double-fluorescence studies showed
hat following AAV infection both nucleolin and AAV cap-
ids accumulated in the nucleus with similar kinetics and
hat nucleolin could be used to precipitate AAV capsids.
n contrast, nucleolin does not bind to denatured AAV
apsid proteins.
Human nucleolin, a 713-amino-acid phosphoprotein
lso known as C23, is the major nucleolar protein in
apidly dividing eukaryotic cells (Lapeyre et al., 1987).
lthough nucleolin is barely detectable in resting cells, it
epresents up to 5% of the nucleolar protein in exponen-
ially growing cells (Bugler et al., 1982). Nucleolin is a
ultifunctional protein in the nucleolus and has been
mplicated in the control of the transcription of rRNA
enes (Olson et al., 1983; Bouche et al., 1984) and the
ackaging of nascent ribosomal RNA (Herrera and Ol-
on, 1986; Bugler et al., 1987; Ginisty et al., 1998), and
ore recently nucleolin was identified as one compo-
ent of the B-cell-specific transcription factor and switch-
inding protein LR1 (Hanakahi et al., 1997). In addition
ucleolin appears to act as a shuttle between the cyto-
lasm and the nucleolus, with a role in nucleolar–cyto-
lasmic transportation (Borer et al., 1989; Schmidt-Zach-
ann et al., 1993). Nucleolin has also been identified on
he cell surface and has been reported to act as a
eceptor for lipoprotein (Semenkovich et al., 1990), fruc-
osyl-lysine (Krantz et al., 1995), coxsackie B viruses (de
erdugo et al., 1995), and most recently HIV (Callebaut et
l., 1998). On the cell surface it acts as a substrate for
inases including ecto-protein kinase (Jordan et al., 1994)
nd protein kinase C-z (Zhou et al., 1997), and it has been
uggested that nucleolin may have a function in signal-
ng between the cell surface and the nucleus.
The role of the interaction of nucleolin with intact
AV-2 particles is unknown, although its presence in the
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377NUCLEOLIN BINDS TO AAV-2 CAPSIDucleolus may be significant. Cellular fractionation and
mmunofluorescence studies have shown that AAV cap-
id assembly occurs in the nucleolus (Wistuba et al.,
995, 1997), and in studies using baculovirus expressed
apsid proteins, a HeLa cell extract containing the frac-
ion of highly soluble nuclear protein was required for
ignificant oligomerization of the proteins and capsid
ormation (Steinbach et al., 1997). Furthermore, the cap-
id formation begins in the nucleolus and then extends
o other sites of the nucleus, especially in the presence
f Rep and AAV DNA (Wistuba et al., 1997), suggesting
hat nucleolar components are required for the initiation
f AAV capsid assembly. Nucleolin is an excellent can-
idate for such a nucleolar protein. Recently, nucleolin
as been shown to bind to hepatitis delta antigen
HDAg), is critical for HDAg nucleolar targeting, and is
nvolved in the modulation of HDV replication (Lee et al.,
998). It has also been shown that nucleolin has a critical
ole in the assembly of ribosomes, providing a hydropho-
ic environment essential for the formation of three-
imensional conformational structure (Bugler et al.,
FIG. 7. Flow cytometry analysis. Mo-7e, K562, Hep-2, and RD cells (10
n PBS with 1% BSA, and FITC-labeled secondary antibody was incuba
tained with propidium iodide solution and the viable cells were analyz
mouse isotype IgG1 antibody as control.982). Perhaps nucleolin has a similar role in the confor-
ational changes necessary for AAV capsid assembly.
In addition nucleolin may have a role in directing the
ascent capsid proteins to the nucleolus for assembly.
mmunofluorescence studies have shown that VP1 and
P2 proteins appear to collect in the nucleolus, and
xpression of the individual AAV capsid proteins has
hown that although VP3 is distributed between nucleus
nd cytoplasm, VP1 and VP2 preferentially accumulate in
he cell nuclei (Wistuba et al., 1997). The signaling for this
s unknown, as VP1 and VP2 do not appear to contain
uclear localization signals. However, nucleolin does
ontain nuclear localization signals, and it may be
hrough interaction with nucleolin that the nascent VP1
nd VP2 are transported to the nucleus. A similar role
as been proposed for the interaction of nucleolin with
oth HDAg and SV40 large T antigen (Lee et al., 1998;
ue et al., 1993). In contrast to other studies, we were
nable to identify a specific nucleolin-binding motif on
he VP1 and VP2 proteins, as binding appeared to be at
east partially conformationally dependent.
incubated with CC98 monoclonal antibody for 30 min on ice, washed
the cells for a further 30 min. After the cells were washed, they were
Coulter cytoflow machine. Fluorescence was compared to that using6) were
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378 QIU AND BROWNA direct role in the encapsidation of AAV DNA in the
ascent capsids is attractive but less likely. Previous
tudies have shown that nucleolin binds to ssDNA (Sapp
t al., 1989), and in studies with the related parvovirus
VM, it was shown that nucleolin binds with high affinity
o a specific 220-nucleotide nucleolin-binding domain in
he 39 portion of the viral genome (Avalosse et al., 1989;
arrijal et al., 1992). Although we could demonstrate
ome binding of nucleolin to the full-length AAV genome
data not shown), we were unable to show similar spe-
ific binding with different regions of the AAV genome.
FIG. 8. Colocalization of AAV capsid and the endogenous nucleolin
n infected cells as detected by double-immunofluorescence staining at
ifferent time points postinfection. KB cells on slides were infected with
AV-2 and Ad5 and examined at different time points. The cells were
ixed in cold methanol and acetone and incubated with hybridoma
upernatant of A 20 (mAb to AAV capsid, IgG3) and CC98 (mAb to
uman nucleolin, IgG1), with TRITC-conjugated anti-mouse IgG3 and
ITC-conjugated anti-mouse IgG1 as second antibodies. The same
ield was visualized with different filters under UV. (a, c, e, and g) were
tained for AAV capsid; (b, d, f, h, and i) were stained for nucleolin; (j)
oechst stain showing nuclear counterstain. The bar corresponds to
0 mm.or AAV other studies have shown that viral ssDNA is
ssociated with Rep proteins and appears to accumulate
n nucleoplasmic clusters, before encapsidation in the
reformed capsids (Wistuba et al., 1997), although cap-
id formation is a prerequisite for the accumulation of
sDNA (Myers and Carter, 1981). Mutation analysis of
nfectious plasmids has shown that although VP2 and
P3 proteins are sufficient for the accumulation of
sDNA and also capsid production, VP1 seems to be
equired for production of infectious particles (Smuda
nd Carter, 1991; Muralidhar et al., 1994).
Similarly there is insufficient evidence to suggest that
ucleolin on the cell surface plays a role in virus attach-
ent, absorption, and/or penetration. Nucleolin has
een suggested as the receptor for coxsackie B viruses
de Verdugo et al., 1995), HIV (Callebaut et al., 1998), and
ipoproteins (Semenkovich et al., 1990). We could dem-
nstrate that nucleolin was present on the cell surface of
eLa S3 and K562 cells (AAV-2 permissive cell lines) and
o-7e cells (an AAV nonpermissive cell line; Ponnazha-
an et al., 1996); in contrast we were unable to detect
ucleolin on the cell surface of Hep-2 and RD cells, yet
he cells appeared to be fully susceptible to wild-type
AV infection. Thus, although a role in the early stages of
nfection cannot be excluded, nucleolin on the cell mem-
rane does not appear to be critical for viral replication.
In conclusion, we have shown that AAV-2 capsids
nteract both in vivo and in vitro with the 110-kDa nuclear
hosphoprotein, nucleolin. Ideally, we would have liked
o examine the effect of AAV-2 on nucleolin-negative
ells. Although nucleolin-negative cells are described in
he literature (i.e., RD cells), we could demonstrate that
lthough they did not have nucleolin on the cell surface,
ucleolin was present in the nucleus (data not shown).
e were unable to find any cell lines that did not have
ucleolin in the nucleus; no nucleolin knockout lines or
ells have been described. However, with the known role
f nucleolin in cytoplasmic–nuclear shuttling and ribo-
omal assembly, the dependence of both nucleolin and
apsid assembly on actively dividing cells, and the
nown assembly of AAV capsids in the nucleolus, we
ropose that nucleolin plays a key role in AAV replica-
ion, primarily at the level of capsid assembly.
MATERIALS AND METHODS
iruses and cells
Seed viruses (AAV-2 and adenovirus type 5, Ad5) and
ells (KB, 293, HeLa-S3, RD, K562, HEp-2, and SP2/0
ells) were purchased from the American Type Culture
ollection (ATCC, Rockville, MD). KB and 293 cells were
aintained as a monolayer in Dulbecco’s modified Ea-
le’s minimal essential medium (DMEM); HeLa-S3 cells
ere maintained as a suspension culture in F12 medium;
562, RD, HEp-2, SP2/0, and hybridoma cells were main-
ained in RPMI 1640; and Mo-7e cells (Avanzi et al., 1990)
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379NUCLEOLIN BINDS TO AAV-2 CAPSIDere maintained as a suspension culture in RPMI 1640
ith 20 U/ml of GM-CSF. All media were supplemented
ith 10% fetal bovine serum and penicillin–streptomycin,
nd all cultures maintained at 37°C in a humidified
tmosphere containing 5% CO2.
AV-2 preparation
For production of AAV-2, KB or 293 cells were grown to
0% confluence and infected with AAV-2 (multiplicity of
nfection, m.o.i. 5 10) and Ad5 (m.o.i. 5 5). The cells were
ncubated at 37°C and 5% CO2 for 40–48 h and harvested
efore the appearance of significant cell lysis. For AAV
irus stock preparation, infected cells and media were
rozen and thawed three times at 220 and 37°C, respec-
ively. Debris was removed by centrifugation, and the
upernatant was collected and heated to 56°C for 30 min
o inactivate adenovirus.
For large-scale purification of AAV-2, 25 flasks (175
m2) of KB cells were coinfected with AAV-2 and Ad5, and
he infected cells were harvested at 40–48 h by resus-
ension in 20 ml of PBS and sonicated to lyse the cells.
fter the addition of sodium deoxycholate (final concen-
ration 2%) and incubation at 37°C for 30 min a further
olume of PBS was added and sonication was repeated.
fter cell debris had been removed by high-speed cen-
rifugation (12,000 g for 30 min), the supernatant was
djusted to a density of 1.40 g/ml by the addition of CsCl
owder and ultracentrifuged at 150,000 g for 40 h. AAV-2
articles were purified by combining the virus-containing
ractions (density 1.38–1.42 g/ml), repeating the CsCl gra-
ient a total of three times, and finally collecting the
irions and removing the CsCl by dialysis against PBS at
°C for 2 days. Purity of the AAV was assessed by
DS–PAGE, silver-staining, and specifically Western blot-
FIG. 9. Immunoprecipitation and Western blotting analysis of interactio
nfected with AAV and Ad5; cytoplasm and nucleus fractions were ex
ntibody (A), and A20, AAV-2 virion monoclonal antibody (B). Immuno
embrane, and detected with B1 antibody (detects all the capsid prote
ostinfection; N 0, 12, 18, and 24: nuclear extraction at 0, 12, 18, and 24
4 h postinfection; control 2: purified AAV-2 virions immunoprecipitateding for contamination with adenovirus (including Ad
exon protein using antibody from Biodesign, Kenne-
unk, ME) and AAV Rep protein. Protein concentration
as measured with a BCA Kit (Pierce Chemical Co.,
ockford, IL).
Iodination of AAV was performed using Iodo-Beads
Pierce Chemical Co.) according to the manufacturer’s
rotocol. In brief, 1 mCi of 125I in 190 ml of PBS was
ncubated with two prewashed Iodo beads at room tem-
erature for 5 min, 200 ml of purified AAV (100 mg) was
dded and incubated for a further 5 min, and the reaction
as stopped by removal of the Iodo beads. Unincorpo-
ated 125I was removed by overnight dialysis against
BS.
embrane fraction preparation
HeLa cells were harvested by centrifugation from sus-
ension cultures, and all subsequent procedures were
erformed on ice with all buffers containing Protease
nhibitor Cocktail (Boehringer Mannheim, Germany); 2 3
08 cells were used for each preparation. Cells were
ashed once in PBS and the cell pellets were resus-
ended in 2.5 ml TE (10 mM Tris–HCl, pH 7.5, 1 mM
DTA) buffer. After incubation on ice for 10 min, cells
ere Dounce-homogenized, and the cells were checked
or lysis by Trypan blue staining. Immediately after ho-
ogenization, nuclei were pelleted by mild centrifugation
400 g for 4 min), and the supernatant was recentrifuged
t 18,000 g for 15 min to collect the soluble cytoplasmic
raction. The precipitate containing cell membranes was
urther purified by suspension in 85% sucrose followed
y centrifugation through a 10–85% sucrose gradient
olution (50,000 g at 4°C for 16 h), and the 10–65%
nterphase was collected by side puncture. The mem-
een nucleolin and AAV capsid in cytoplasm and nucleus. KB cells were
at different time points, and immunoprecipitated by CC98, nucleolin
itated proteins were run on SDS–PAGE, transferred to nitrocellulose
AAV-2). C 0, 12, 18, and 24: cytoplasm extraction at 0, 12, 18, and 24 h
infection. Control 1: avb5 monoclonal antibody with nuclear extract at
98. Arrow indicates the mouse IgG band.n betw
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380 QIU AND BROWNrane proteins were washed once in TE buffer, and the
embrane fraction pellet was stored at 270°C until use.
In some experiments, infected cells were harvested in
similar manner, and the nuclear, cytoplasmic, and
embrane fractions were collected and stored sepa-
ately.
ucleolin preparation and nucleolin-specific
ntibodies
Crude nucleolin was extracted by ammonium sulfate
recipitation as previously described (Warrener and Pet-
yshyn, 1991; Yang et al., 1994). Nucleolin purified by
lectroendosmosis after ammonium sulfate precipitation
Warrener and Petryshyn, 1991) and rabbit anti-nucleolin
olyclonal antibody were provided by Dr. H. K. Kleinman
NIDR, NIH; Kibbey et al., 1995). Mouse monoclonal an-
ibodies to nucleolin were provided by Dr. H. Busch,
aylor College of Medicine (MS3, MS4; Valdez et al.,
995), Dr. J-S. Deng, Pittsburgh School of Medicine (D3;
eng et al., 1996), and Dr. N-H. Yeh, Yang-Ming College,
aiwan (CC98; Chen et al., 1991).
onoclonal antibody production
Balb/c mice (4 weeks old) were immunized with CsCl-
urified AAV-2 (100 mg) emulsified with an equal volume
f TiterMax Gold adjuvant (CytRx Corp., Norcross, GA).
our weeks later the spleen was harvested and cells
ere fused with SP2/0 myeloma cells with 20% PEG.
ositive hybridoma clones were screened by ELISA us-
ng microtiter plates coated with purified AAV-2 and con-
irmed by Western blotting. Antibody was typed with a
ybridoma isotyping kit (Boehringer Mannheim) accord-
ng to the manufacturer’s protocol. Specificity of the
onoclonal antibodies was tested by Western blot and
y an in-house ELISA. In brief, microtiter plates (Nunc)
ere coated with purified AAV-2 virions (3–5 mg/ml) in
00 mM sodium carbonate buffer, pH 9.6, and blocked
ith 1% BSA in PBS. Hybridoma supernatant was added
o the wells and incubated at 37°C for 30 min, followed
y a horseradish peroxidase (HRPO)-conjugated goat
nti-mouse IgG/M secondary antibody (Biosource Inter-
ational, Camarillo, CA), and color development by ABTS
ubstrate (Boehringer Mannheim).
is fusion protein expression of the unique VP1 and
P2 protein sequence
The VP1 and VP1/2 unique sequences of AAV-2 (nt
203–2614 for VP1; nt 2203–2809 for VP1/2) were ex-
ressed as His fusion proteins using the pBAD fusion
rotein expression system. Specifically the nucleotide
equences were amplified by primers PF1 (GAA-GAT-
TG-CAT-GGC-TGC-CGA-TGG-TTA-T) and PR1 (CGG-
AT-TCC-CTT-AAC-AGG-TTC-CTC-AAC) or PF1 and PR2
CGG-AAT-TCC-CGT-ATT-AGT-TCC-CAG-ACC) using the
AV2 plasmid as template (Laughlin et al., 1983). TheCR amplicons were digested with restriction enzymes
glII and EcoRI and ligated into the pBAD His 1 fusion
rotein expression vector (Invitrogen Inc., Carlsbad, CA).
ransformation of bacteria and induction of expression
ith 0.2% arabinose were according to the manufac-
urer’s protocol.
icrosequencing of the copurifying protein
CsCl-purified AAV (200 mg) was analyzed on a SDS–8%
AGE gel, and proteins were visualized by Coomassie
lue R-250 staining. The 110-kDa protein band was ex-
ised, placed in a 1.5-ml Eppendorf tube, washed twice
ith 50% acetonitrile, and sent to the Harvard Micro-
hemistry Facility (Cambridge, MA) for enzyme digestion,
PLC separation, and microsequencing.
iral overlay and Western blot assays
The virus overlay protein binding assay (VOBPA) was
erformed as previously described (Mizukami et al.,
996). Specifically, proteins were separated by SDS–7%
AGE and electrotransferred onto a nitrocellulose mem-
rane, and the membrane was blocked by incubation
ith 5% nonfat dried milk in PBS with 0.1% Tween 20
PBST) for 2 h at room temperature. The membrane was
ither incubated with 125I-labeled AAV at RT for 2 h,
ashed thoroughly with PBST, and then exposed to X-ray
ilm (direct VOPBA) or alternatively incubated with puri-
ied AAV at RT for 1 h, thoroughly washed with PBST,
ncubated with a mouse monoclonal antibody specific to
ntact AAV virions (A20, American Research Products
nc., Belmont, MA) and then with a HRPO-conjugated
econdary antibody (Biosource International, Camarillo,
A), and underwent final detection by chemiluminescent
ubstrate (Pierce Chemical Co.). In some experiments
ucleolin was substituted for viral particles, and bound
ucleolin was detected with nucleolin-specific monoclo-
al antibody.
Western blot analysis was performed in a similar man-
er, with blocking of the nitrocellulose with 5% nonfat
ried milk in PBST for 1 h at RT prior to incubation with
ntibody and detection with HRPO-conjugated second-
ry antibody and chemiluminescent substrate.
AV pull-down assay
Magnetic beads coated with purified AAV were pre-
ared using tosyl-activated Dynabeads M280 (Dynal
. S., Oslo, Norway) according to the manufacturer’s
rotocol. HeLa S3 membrane fractions prepared as
bove (5–10 mg/ml) were solubilized in 1% n-dodecylma-
oside (DMT) in PBS with protease inhibitor cocktail
Boehringer Mannheim) at 4°C for 1 h and centrifuged at
0,000 g at 4°C for 30 min to precipitate insoluble frac-
ions, and the supernatant was mixed with 100 ml AAV-
oated magnetic beads. The beads were washed times
our with 0.5% DMT in PBS and boiled in protein loading
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381NUCLEOLIN BINDS TO AAV-2 CAPSIDuffer, and protein from the equivalent of 50 mg of mem-
rane preparation was loaded onto SDS–PAGE for fur-
her analysis.
low cytometry analysis
Cells (106) were washed with 1% BSA in PBS and
ncubated with either 200 ml of hybridoma supernatant
C98 or an isotype (IgG1) control for 30 min on ice. Cells
ere rewashed and incubated with FITC-conjugated
oat anti-mouse IgG secondary antibody (Biosource In-
ernational) and analyzed by flow cytometry.
ntibody immunoprecipitation
Cytoplasm and nuclear extracts (200 ml) prepared as
bove were mixed with equal volumes of lysis buffer (50
M Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.2% deoxy-
holate, protease inhibitor cocktail) and monoclonal an-
ibody (hybridoma supernatants A20 and CC98 and as a
ontrol, antibody against integrin avb5; Chemicon Inter-
ational Inc., Temecula, CA). After incubation for 1 h at
°C, 150 ml of prewashed anti-mouse IgG-coated mag-
etic beads (Dynal A.S.) was added and the mixture was
ncubated at 4°C for a further hour. The beads were
ashed with lysis buffer four times, boiled in protein
oading buffer, and analyzed by SDS–PAGE and Western
lotting.
ouble-staining of immunofluorescence
KB cells were grown on chamber slides (Lab-Tek,
agle Nunc International Co.), washed in PBS, and fixed
n methanol (4°C for 5 min) and then in acetone (4°C for
min). The undiluted hybridoma supernatants (A20, IgG3
o intact capsid; CC98, IgG1 to human nucleolin) were
ncubated with the cells for 1 h at 37°C in a moist
hamber, and the cells were washed three times in PBS
nd incubated for 1 h at 37°C together with FITC-conju-
ated goat anti-mouse IgG1 and TRITC-conjugated anti-
ouse IgG3 secondary antibodies (Southern Biotechnol-
gy Associates, Inc., Birmingham, AL) diluted 1:50 in
BS–0.1% BSA. The samples were washed as before, air
ried, and examined by UV microscopy.
Indirect immunofluorescence assay for wild-type
AV-2 infection was done in the same manner using a
onoclonal antibody to three AAV capsid proteins, B1
American Research Products Inc., Belmont, MA), and
ITC-conjugated goat anti-mouse secondary antibody.
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